Skip to main content

We are leading a revolution to transform cancer care

We are driven by a bold ambition to redefine cancer care by advancing science, delivering innovative medicines, and leveraging cutting-edge technologies to detect disease earlier, personalise treatments, and improve patient outcomes globally. Join us in shaping the future of oncology.

Search roles

Back to locations map

Revolutionising cancer care

We have a bold ambition to eliminate cancer as a cause of death. We aim to deliver innovative medicines across multiple scientific platforms and pioneer new technologies to detect and diagnose cancer earlier, personalise treatment, and optimise the care experience for all patients. We have a vision where cancer can be outsmarted and, in some cases, even cured. We are focusing our efforts on key tumour areas and developing a broad portfolio of personalised treatments that target different subtypes across all stages of disease.

Innovation alone won’t solve cancer – it takes extraordinary people working toward the same goal to achieve this collective purpose. Recognising this, we are accelerating our vision to transform care through partnerships across the healthcare ecosystem that improve access and delivery to improve patient care.

Inside Our Oncology Business Unit

Disrupt to redefine cancer treatment

We’re all here to make an impact – to achieve our bold ambition of eliminating cancer as a cause of death. In the Oncology Business Unit we relentlessly follow the science, challenging the status quo to deliver more effective treatments to patients in need. Our commitment means we purposefully push back the limits of knowledge to change the practice of medicine. To ensure no patient is left behind, no matter what stage of disease.

It’s our launch excellence and commercial effectiveness that will make the difference, empowering us to deliver the true value and potential of our life-changing medicines. Fuelled by partnerships, both internally and externally, we bring together diverse minds, knowledge and skills, sharing and working together, comfortable learning from failures. Here you’ll find varied opportunities, access to industry-leading research and technology, and product launches from a pipeline like no other. 

Come and be a part of the team that makes it happen. Together we can make this the greatest decade ever in the fight against cancer.

Key reasons to join Oncology Business Unit

Our tumour areas of focus

Our scientific approach is anchored in the ambition to address unmet patient needs to research and develop next-wave therapies with the greatest potential for patient impact. We are focusing our efforts on key tumour areas including lung, breast, gastrointestinal, gynaecological, genitourinary and haematology.

We are striving to make cures a reality for the millions of people across the world living with cancer every day.

 

Our people

We foster an inclusive and entrepreneurial culture where diversity drives innovation and progress, and where every voice is encouraged to speak up and drive change. Together, we are inspiring and supporting the next-generation of scientists, engineers and healthcare professionals to transform the patient experience in oncology.

We are building one of the fastest-growing, highest-performing oncology organisations in the industry

Our scientific platforms

Across our intentionally designed portfolio, we are harnessing a breadth of scientific platforms to attack cancer from multiple angles. Each platform is designed to leverage emerging technologies that deepen biological understanding and help to personalise treatment with the ambition to bring more patients the benefits of innovation.

Together, they form the foundation of our strategy to transform cancer care.

Our pipeline

We aim to revolutionise cancer care through our portfolio, our pipeline and our people. Through the relentless quest for innovation, we have created one of the most diverse portfolios and pipelines in the industry. We are balancing focus on our industry-leading pipeline with the active life-cycle management of our existing medicines.

We follow the science, wherever it takes us, in pursuit of the medicines that improve patient outcomes.

A career in the BioPharmaceuticals Business Unit at AstraZeneca has purpose, meaning and impact. Your work and contributions will help enhance the quality of life for millions of patients around the world living with Cardiovascular, Renal, Metabolic (CVRM), Respiratory, Inflammatory and Autoimmune (RIA) diseases.

Ruud Dobber - EVP Biopharmaceutical Business Unit

Featured roles

View all of our available opportunities

Join our Talent Network

Be the first to receive job updates and news from AstraZeneca

Sign up